Press release
Orphan Drugs Market Size, Growth, Leading Companies and Global Industry Demand 2022-2027
COVID-19 Impact Analysis:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a Free PDF Sample of the Report: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Orphan drugs are pharmaceutical products manufactured to meet a specific health requirement of the public. The products are used for the prevention, diagnosis, and treatment of rare medical disorders. Orphan drugs have a limited market and are produced for a small group of patients. The drugs are effective against numerous metabolic, oncological, immunologic, hematologic, infectious, and neurological diseases. Apart from this, they help treat lymphoma, cystic fibrosis, leukemia, pancreatic cancer, glioma, multiple myeloma and renal cell carcinoma, and ovarian cancers.
Market Trends and Drivers:
The global orphan drugs market is primarily driven by the emergence of new pharmaceutical drug manufacturers. In line with this, the rising prevalence of cancer and rare genetic disorders has significantly surged the demand for orphan drugs, which is further creating a positive outlook for the market. Moreover, governments of various nations are implementing policies to inhibit the spread of contagious diseases, which is providing a considerable boost to the market growth. Besides this, increasing investments by key players in research and development (R&D) activities for novel drug offerings, a rising number of clinical trials, and significant improvements in healthcare infrastructure are supporting the market growth.
Orphan Drugs Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the orphan drugs market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
• AbbVie Inc.
• Alexion Pharmaceuticals Inc.
• Amgen Inc.
• Biogen Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG (Roche Holding AG)
• Jazz Pharmaceuticals Plc
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
Key Market Segmentation:
The report has segmented the global orphan drugs market on the basis of drug type, disease type, phase, top selling drugs, distribution channel and region.
Breakup by Drug Type:
• Biological
• Non-Biological
Breakup by Disease Type:
• Oncology
• Hematology
• Neurology
• Cardiovascular
• Others
Breakup by Phase:
• Phase I
• Phase II
• Phase III
• Phase IV
Breakup by Top Selling Drugs:
• Revlimid
• Rituxan
• Copaxone
• Opdivo
• Keytruda
• Imbruvica
• Avonex
• Sensipar
• Soliris
• Others
Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2382&flag=C
Key Highlights of the Report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs Market Size, Growth, Leading Companies and Global Industry Demand 2022-2027 here
News-ID: 2707530 • Views: …
More Releases from IMARC Group
Setup Report on Asphalt Manufacturing Plant 2025: Feasibility Study and Profitab …
Asphalt is a specialized construction material designed to provide durable surfacing for roads, highways, and infrastructure projects, ensuring efficient pavement performance and extended operational life. This material is typically a hot-mix composition of aggregates and bitumen that balances structural strength with flexibility to support traffic loads, weather resistance, and longevity. Its quality directly influences pavement durability, safety, and overall infrastructure efficiency.
Setting up an asphalt manufacturing plant involves establishing facilities for…
Setting Up a Neem Oil Processing Plant 2025: Cost, Key Insights and Investment O …
Neem oil is a specialized natural product designed to provide solutions for agricultural, pharmaceutical, and cosmetic applications, ensuring efficient pest management and extended crop protection time. This oil is typically lightweight, high-potency botanical extract that balances active compound concentration with purity to support pest control effectiveness, therapeutic properties, and product stability. Its quality directly influences application efficacy, safety, and overall product performance.
Setting up a neem oil processing plant involves establishing…
How to Setup Chocolate Manufacturing Plant 2025: Complete Investment Guide for I …
Chocolate is a specialized confectionery product designed to provide taste satisfaction and sensory pleasure for consumers, ensuring delightful eating experience and extended shelf life. These products are typically smooth-textured, high-quality cocoa-based confections that balance flavor profile with consistency to support taste appeal, texture quality, and freshness. Their quality directly influences consumer satisfaction, safety, and overall product excellence.
Setting up a chocolate manufacturing plant involves establishing facilities for cocoa processing, conching, and…
India Sand Market Size to Hit USD 958.0 Million (5.10% CAGR) by 2033 | Get Free …
According to IMARC Group's report titled "India Sand Market Size, Share, Trends and Forecast by Type, Application, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
Short Summary:
The India sand market size reached USD 582.6 Million in 2024 and is projected to reach USD 958.0 Million by 2033, growing at a CAGR of 5.10% (2025-2033). The market expansion is driven…
More Releases for Orphan
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry …
Market Overview:
According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
